UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39832 Great Elm Group, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorpor ...

Great Elm Group, Inc. (NASDAQ:GEG) Q4 2023 Earnings Conference Call September 21, 2023 8:30 AM ET Company Participants Adam Yates - MD Jason Reese - CEO Keri Davis - CFO Conference Call Participants Nathan Stewart - Capital Advisors Operator Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Great Elm Group Fiscal 2023 Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. A ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39832 GREAT ELM GROUP, INC. (Exact name of Registrant as specified in its charter) Delaware 85-3622015 (State or other jurisdiction of in ...

Financial Data and Key Metrics Changes - For the quarter, revenues increased by 92% year-over-year, driven by higher assets under management and management fees related to GECC and Monomoy [29] - Adjusted EBITDA loss for the quarter was $1.2 million compared to $1.6 million in the prior year period [15] - The company reported a net loss from continuing operations of $0.5 million compared to a net loss of $6.5 million in the prior year period, primarily due to $2 million in net realized and unrealized gains on investments [29] Business Line Data and Key Metrics Changes - Assets under management (AUM) reached $631 million as of March 31, 2023, a 2% increase from the prior quarter and a 4% increase fiscal year-to-date [29] - Fee-paying AUM grew to $439 million, up 1% quarter-to-date and over 8% fiscal year-to-date [29] Market Data and Key Metrics Changes - The company completed two significant transactions, generating over $70 million of cash to GEG's balance sheet from the sale of its interests in Forest Investments and the DME business [21] - The company has not seen a credit crunch affecting its ability to fund transactions, instead identifying more opportunities due to banks pulling out of the market [16] Company Strategy and Development Direction - The company has transformed from a diversified holding company to a focused alternative asset manager, aiming to grow assets under management, improve profitability, and expand its platform [20] - The management highlighted a healthy pipeline of new business opportunities and a clean liquid balance sheet to execute upon them [20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth potential of Monomoy properties despite a slowdown in transactions due to high cap rates in the industrial space [17] - The company is well-positioned to achieve its strategic goals and is focused on proving its ability to grow and improve profitability [20] Other Important Information - The company announced the resignation of its CEO, with Jason Reese appointed as the new CEO [4] - The company has a strong institutional back office capable of servicing its growing platform [20] Q&A Session Summary Question: What is the impact of the credit crunch on spreads at GECC and the company's ability to fund transactions? - Management indicated that they have not seen a credit crunch affecting their funding capabilities and are actually seeing more opportunities for transactions [16] Question: What is the growth strategy now that Great Elm does not have a significant NOL? - Management acknowledged that while they still have an NOL, it is not as large as before, and they are optimistic about the Monomoy space despite current market conditions [17]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39832 Great Elm Group, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporatio ...

Great Elm Group, Inc. (NASDAQ:GEG) Q2 2023 Earnings Conference Call February 14, 2023 9:00 AM ET Company Participants Adam Yates - Managing Director Jason Reese - Executive Chairman Peter Reed - Chief Executive Officer Brent Pearson - Chief Financial Officer Operator Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Great Elm Group, Incorporated Fiscal 2023 Second Quarter Earnings Conference Call. All ...

**PART I. FINANCIAL INFORMATION** [Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) Strategic divestitures resulted in a **$29.7 million** net income, driven by asset sales and investment gains, with DME reclassified as discontinued operations [Unaudited Condensed Consolidated Balance Sheets](index=4&type=section&id=Unaudited%20Condensed%20Consolidated%20Balance%20Sheets) Total assets remained stable at **$169.7 million**, driven by reclassification of **$76.6 million** in DME assets held for sale, increasing equity to **$59.1 million** Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | Dec 31, 2022 | June 30, 2022 | | :--- | :--- | :--- | | **Total Assets** | **$169,690** | **$168,087** | | Current assets held for sale | $76,629 | $8,464 | | Non-current assets held for sale | $0 | $69,561 | | **Total Liabilities** | **$107,591** | **$125,833** | | Current liabilities held for sale | $18,047 | $15,003 | | **Total Stockholders' Equity** | **$59,122** | **$40,029** | [Unaudited Condensed Consolidated Statements of Operations](index=5&type=section&id=Unaudited%20Condensed%20Consolidated%20Statements%20of%20Operations) Net income reached **$29.7 million**, a significant improvement from prior-year loss, driven by a **$10.5 million** gain on subsidiary sale and **$22.2 million** investment gains Statement of Operations Highlights (in thousands, except per share data) | Metric | Q4 2022 | Q4 2021 | Six Months 2022 | Six Months 2021 | | :--- | :--- | :--- | :--- | :--- | | **Revenues** | **$1,879** | **$1,021** | **$3,739** | **$2,004** | | Operating Loss | $(2,788) | $(2,567) | $(4,744) | $(4,505) | | Gain on sale of controlling interest in subsidiary | $10,524 | $0 | $10,524 | $0 | | Net realized and unrealized gain (loss) on investments | $22,242 | $(1,821) | $15,445 | $(1,835) | | **Net Income (Loss) from Continuing Operations** | **$29,693** | **$(4,790)** | **$20,190** | **$(7,539)** | | Net Income from Discontinued Operations | $35 | $631 | $999 | $3,486 | | **Net Income (Loss) Attributable to GEG** | **$29,530** | **$(4,238)** | **$21,239** | **$(4,438)** | | Diluted EPS | $0.74 | $(0.16) | $0.55 | $(0.17) | [Unaudited Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Unaudited%20Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Operating activities provided **$1.3 million** cash, investing activities provided **$10.7 million** from asset sales, and financing used **$18.4 million** for debt repayment Cash Flow Summary (in thousands) | Activity | Six Months Ended Dec 31, 2022 | Six Months Ended Dec 31, 2021 | | :--- | :--- | :--- | | Net cash provided by operating activities | $1,344 | $3,110 | | Net cash provided by (used in) investing activities | $10,654 | $(3,124) | | Net cash (used in) provided by financing activities | $(18,402) | $588 | | **Net decrease in cash and cash equivalents** | **$(3,310)** | **$(1,980)** | | Cash and cash equivalents at end of period | $18,971 | $16,765 | - Investing activities were significantly impacted by the receipt of **$17.7 million** from the sale of a controlling interest in a subsidiary[20](index=20&type=chunk) - Financing activities were dominated by an **$18.4 million** principal payment on a related party note payable[22](index=22&type=chunk) [Unaudited Notes to Condensed Consolidated Financial Statements](index=10&type=section&id=Unaudited%20Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Notes detail the **$18.4 million** Forest sale (61% interest) yielding a **$10.5 million** gain, DME reclassification as held for sale, and subsequent sales of remaining Forest interest for **$26.5 million** and DME for **$80.0 million** - The company's business is focused on investment management, growing a portfolio of permanent capital vehicles[24](index=24&type=chunk) - On December 30, 2022, GEG sold a **61%** controlling interest in Forest to J.P. Morgan for **$18.4 million** in cash, recognizing a gain of **$10.5 million**[41](index=41&type=chunk) - The Durable Medical Equipment (DME) business (HC LLC) was classified as held for sale and discontinued operations as of December 31, 2022[27](index=27&type=chunk)[45](index=45&type=chunk) - Subsequent to the quarter end, on January 3, 2023, the company sold HC LLC to Quipt for **$80.0 million**[104](index=104&type=chunk) - On January 17, 2023, the company exercised a put option to sell its remaining **19%** interest in Forest for **$26.5 million** in cash[105](index=105&type=chunk) - Following the sale of Forest, the company's available federal Net Operating Loss (NOL) carryforwards were reduced from approximately **$821 million** to **$154 million**[99](index=99&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=28&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the company's transition to investment management with **$619.0 million** AUM, enhanced liquidity from **$70.9 million** cash post-quarter-end, and reduced NOLs to **$154 million** after divestitures - GEG is now focused on being an investment management company with approximately **$619.0 million** in assets under management as of December 31, 2022[106](index=106&type=chunk) - The company completed two major strategic transactions: the sale of its controlling interest in Forest in December 2022 and the sale of its DME business (HC LLC) in January 2023[107](index=107&type=chunk)[108](index=108&type=chunk) - Subsequent to quarter end, the company received an additional **$70.9 million** in unrestricted cash from the completion of the HC LLC sale and the exercise of the Forest put option[126](index=126&type=chunk) Results of Operations Summary (in thousands) | Metric | Q4 2022 | Q4 2021 | % Change | | :--- | :--- | :--- | :--- | | Revenue | **$1,879** | **$1,021** | **84%** | | Operating Loss | **$(2,788)** | **$(2,567)** | **9%** | | Other income (expense), net | **$32,250** | **$(2,276)** | NM | | Income (loss) before income taxes | **$29,462** | **$(4,843)** | NM | - The company's federal NOL carryforwards were reduced from **$821 million** to approximately **$154 million** following the sale of its interest in Forest[110](index=110&type=chunk)[119](index=119&type=chunk) [Results of Operations](index=29&type=section&id=Results%20of%20Operations) Revenues increased **84%** to **$1.9 million** due to the Monomoy UpREIT management agreement, while operating costs rose by **$1.1 million**, and other income of **$34.2 million** significantly boosted pre-tax income - Revenue increased by **$0.9 million** for the quarter and **$1.7 million** for the six months ended Dec 31, 2022, primarily due to the Monomoy UpREIT management agreement acquired in May 2022[115](index=115&type=chunk) - Operating costs increased by **$1.1 million** for the quarter, mainly due to costs associated with servicing the new Monomoy UpREIT management agreement[116](index=116&type=chunk) - Other income for Q4 2022 was **$34.2 million**, comprised of a **$10.5 million** gain on the Sale of Controlling Interest in Forest, a **$24.4 million** unrealized gain on the remaining investment in Forest, and **$1.4 million** in dividends and interest, offset by investment losses[118](index=118&type=chunk) [Liquidity and Capital Resources](index=30&type=section&id=Liquidity%20and%20Capital%20Resources) The company held **$19.0 million** in unrestricted cash, with an additional **$70.9 million** received post-quarter-end, and details outstanding debt including **$26.9 million** GEGGL Notes and **$37.0 million** convertible notes - The company held **$19.0 million** in unrestricted cash and **1,569,787** shares of GECC common stock valued at **$13.0 million** as of December 31, 2022[126](index=126&type=chunk) - Transactions completed in January 2023 provided an additional **$70.9 million** in unrestricted cash available for deployment[126](index=126&type=chunk) Outstanding Borrowings as of Dec 31, 2022 (Principal) | Debt Instrument | Principal Outstanding | | :--- | :--- | | GEGGL Notes (7.25% due 2027) | **$26.9 million** | | Convertible Notes (5.0% due 2030) | **$37.0 million** | | Seller Note (6.5% due 2023) | **$3.7 million** | | Forest Note (9.0% due 2023) | **$19.7 million** | - The **$19.7 million** Forest Note was repaid in full on January 3, 2023[130](index=130&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=32&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) No material changes in market risks have occurred since the fiscal year ended June 30, 2022 - There have been no material changes in market risks since the fiscal year ended June 30, 2022[132](index=132&type=chunk) [Controls and Procedures](index=32&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded disclosure controls and procedures were effective as of December 31, 2022, with no material changes to internal control over financial reporting - The CEO and CFO concluded that as of December 31, 2022, the company's disclosure controls and procedures were effective[133](index=133&type=chunk) - No material changes were made to the company's internal control over financial reporting during the quarter ended December 31, 2022[134](index=134&type=chunk) **PART II. OTHER INFORMATION** [Legal Proceedings](index=32&type=section&id=Item%201.%20Legal%20Proceedings) No changes were required to be disclosed regarding legal proceedings - No changes to legal proceedings were required to be disclosed[136](index=136&type=chunk) [Risk Factors](index=32&type=section&id=Item%201A.%20Risk%20Factors) No material changes have occurred to the risk factors previously disclosed in the Annual Report on Form 10-K - No material changes have occurred to the risk factors disclosed in the last Annual Report on Form 10-K[137](index=137&type=chunk) [Exhibits](index=32&type=section&id=Item%206.%20Exhibits) This section provides an index of exhibits filed with the report, including agreements related to recent transactions and required certifications - The exhibit index lists key documents filed with the SEC, including the Stock Purchase Agreement with J.P. Morgan and the Purchase Agreement with QHM Holdings Inc[140](index=140&type=chunk)

Great Elm Group, Inc. (NASDAQ:GEG) Q1 2023 Earnings Conference Call November 15, 2022 9:00 AM ET Company Participants Adam Yates - Managing Director Peter Reed - Chief Executive Officer Adam Kleinman - President Brent Pearson - Chief Financial Officer Conference Call Participants Operator Good morning. My name is Chris and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Great Elm Group Fiscal 2023 First Quarter Conference Call. [Operator Instructions] Adam Yates, Ma ...

[PART I. FINANCIAL INFORMATION](index=4&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) [Item 1. Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) This section presents Great Elm Group, Inc.'s unaudited condensed consolidated financial statements for the three months ended September 30, 2022, including balance sheets, statements of operations, and cash flows [Unaudited Condensed Consolidated Balance Sheets](index=4&type=section&id=Unaudited%20Condensed%20Consolidated%20Balance%20Sheets) Total assets decreased from **$168.1 million** to **$158.3 million**, primarily due to investments, while total stockholders' equity declined from **$40.0 million** to **$31.0 million** Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | Sep 30, 2022 | June 30, 2022 | | :--- | :--- | :--- | | **Total Assets** | **$158,278** | **$168,087** | | Cash and cash equivalents | $23,265 | $23,595 | | Investments, at fair value | $40,624 | $48,042 | | Goodwill | $52,463 | $52,463 | | **Total Liabilities** | **$124,363** | **$125,833** | | Convertible notes | $35,216 | $35,187 | | Long term debt | $25,597 | $25,532 | | **Total Stockholders' Equity** | **$31,028** | **$40,029** | [Unaudited Condensed Consolidated Statements of Operations](index=5&type=section&id=Unaudited%20Condensed%20Consolidated%20Statements%20of%20Operations) The company reported a **net loss of $8.5 million** for Q3 2022, a significant shift from **net income of $0.1 million** in Q3 2021, despite a **12.3% increase in total revenues** Condensed Consolidated Statements of Operations Highlights (in thousands, except per share data) | Account | Q3 2022 | Q3 2021 | | :--- | :--- | :--- | | Total Revenues | $18,579 | $16,538 | | Operating (loss) income | $(985) | $1,001 | | Net realized and unrealized loss on investments | $(6,797) | $(14) | | Net (loss) income | $(8,539) | $106 | | **Net loss attributable to Great Elm Group, Inc.** | **$(8,291)** | **$(200)** | | **Basic and diluted loss per share** | **$(0.29)** | **$(0.01)** | [Unaudited Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Unaudited%20Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash provided by operating activities significantly improved to **$2.0 million** for Q3 2022, while cash and cash equivalents slightly decreased to **$23.3 million** Condensed Consolidated Statements of Cash Flows Highlights (in thousands) | Cash Flow Activity | Three months ended Sep 30, 2022 | Three months ended Sep 30, 2021 | | :--- | :--- | :--- | | Net cash provided by (used in) operating activities | $2,024 | $(1,034) | | Net cash used in investing activities | $(2,270) | $(3,171) | | Net cash (used in) provided by financing activities | $(84) | $1,614 | | **Net decrease in cash and cash equivalents** | **$(330)** | **$(2,591)** | [Unaudited Notes to Condensed Consolidated Financial Statements](index=10&type=section&id=Unaudited%20Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) These notes detail the company's two operating segments, revenue sources, significant related-party transactions, substantial debt obligations, and **$821 million** in federal NOL carryforwards - The company operates through two main segments: Durable Medical Equipment (DME) and Investment Management, managing respiratory care equipment distribution and various private funds respectively[21](index=21&type=chunk)[34](index=34&type=chunk) Revenue by Source (Three months ended Sep 30, in thousands) | Revenue Source | 2022 | 2021 | | :--- | :--- | :--- | | **Investment Management** | | | | Management fees | $1,302 | $876 | | Property management fees | $274 | - | | Administration and service fees | $284 | $107 | | **Durable Medical Equipment** | | | | Equipment sales | $9,634 | $8,730 | | Service revenue | $1,394 | $1,346 | | Medical equipment rental income | $5,691 | $5,479 | | **Total** | **$18,579** | **$16,538** | - The company holds significant borrowings, including **$26.9 million** in 7.25% GEGGL Notes, **$36.1 million** in 5.0% Convertible Notes, and a **$5.7 million** Seller Note[113](index=113&type=chunk)[120](index=120&type=chunk)[123](index=123&type=chunk)[125](index=125&type=chunk) - As of June 30, 2022, the company had substantial Net Operating Loss (NOL) carryforwards of approximately **$821 million** for federal and **$211 million** for state income tax purposes[159](index=159&type=chunk) Segment Income (Loss) Before Taxes (Three months ended Sep 30, 2022, in thousands) | Segment | Income (Loss) Before Taxes | | :--- | :--- | | Durable Medical Equipment | $6,758 | | Investment Management | $(6,031) | | General Corporate | $(9,070) | | **Consolidated Total** | **$(8,343)** | [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=36&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the company's Q3 2022 performance, highlighting **12% revenue growth** to **$18.6 million** despite a **$8.3 million pre-tax loss** driven by investment losses and increased operating costs - The company operates in two segments: Durable Medical Equipment and Investment Management, with combined assets under management of approximately **$623.9 million** as of September 30, 2022[168](index=168&type=chunk)[170](index=170&type=chunk) - The DME business faced suppressed referral pipelines and PAP device procurement issues due to global supply chain challenges, leading to patient backlogs and missed revenue[175](index=175&type=chunk) - Total revenue for Q3 2022 increased by **$2.0 million** year-over-year, driven by **$1.2 million** in DME revenues and **$0.9 million** from the Monomoy UpREIT management agreement[178](index=178&type=chunk) - Operating costs increased by **$4.0 million** year-over-year, partly due to revenue growth, Monomoy UpREIT costs, and the absence of **$2.4 million** in Employee Retention Credits[179](index=179&type=chunk) - As of September 30, 2022, the company held an unrestricted cash balance of **$23.3 million** and GECC common stock with a fair value of **$16.2 million**[218](index=218&type=chunk) [Results of Operations](index=37&type=section&id=Results%20of%20Operations) Consolidated revenue increased to **$18.6 million** in Q3 2022, driven by growth in both DME and Investment Management segments, despite a **$8.3 million pre-tax loss** due to investment losses Consolidated Operations Summary (in thousands) | Account | Q3 2022 | Q3 2021 | | :--- | :--- | :--- | | Total revenue | $18,579 | $16,538 | | Operating (loss) income | $(985) | $1,001 | | (Loss) income before income taxes | $(8,343) | $105 | - DME revenue increased **7%** year-over-year to **$16.7 million**, driven by organic resupply growth and the MedOne acquisition, despite PAP equipment shortages[182](index=182&type=chunk)[183](index=183&type=chunk)[185](index=185&type=chunk) - Investment Management revenue surged **89%** year-over-year to **$1.9 million**, primarily from Monomoy UpREIT management and property management fees acquired in May 2022[194](index=194&type=chunk)[195](index=195&type=chunk) - General Corporate interest expense increased by **$0.6 million** year-over-year, primarily due to interest on the GEGGL Notes issued in June 2022[208](index=208&type=chunk) [Liquidity and Capital Resources](index=42&type=section&id=Liquidity%20and%20Capital%20Resources) As of September 30, 2022, the company held **$23.3 million** in unrestricted cash, with **$2.0 million** from operations, while maintaining significant debt obligations and an intent to pursue acquisitions - Cash flow from operations was a positive **$2.0 million** for the quarter, a significant improvement from a negative **$1.0 million** in the prior year, driven by non-cash charges[211](index=211&type=chunk)[212](index=212&type=chunk) - The company has significant outstanding debt, including **$26.9 million** GEGGL Notes, **$36.1 million** convertible notes, a **$5.7 million** seller note, and **$35.0 million** in preferred stock, plus an undrawn **$10 million** DME Revolver[220](index=220&type=chunk)[221](index=221&type=chunk)[222](index=222&type=chunk)[223](index=223&type=chunk)[226](index=226&type=chunk) - The company intends to use liquid financial resources for acquisitions and investments, acknowledging that failure to raise additional capital may hinder its strategic growth plan[219](index=219&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=44&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) No material changes in market risks have occurred since the Annual Report on Form 10-K for the fiscal year ended June 30, 2022 - No material changes in market risks have occurred since the Annual Report on Form 10-K for the fiscal year ended June 30, 2022[229](index=229&type=chunk) [Controls and Procedures](index=44&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of September 30, 2022, with no material changes to internal control over financial reporting - The CEO and CFO concluded that the company's disclosure controls and procedures were effective as of September 30, 2022[230](index=230&type=chunk) - No material changes in internal control over financial reporting occurred during the quarter[231](index=231&type=chunk) [PART II. OTHER INFORMATION](index=45&type=section&id=PART%20II.%20OTHER%20INFORMATION) [Legal Proceedings](index=45&type=section&id=Item%201.%20Legal%20Proceedings) No changes regarding legal proceedings were required to be disclosed - No changes regarding legal proceedings were required to be disclosed[234](index=234&type=chunk) [Risk Factors](index=45&type=section&id=Item%201A.%20Risk%20Factors) No material changes from previously disclosed risk factors in the Annual Report on Form 10-K for the fiscal year ended June 30, 2022 - No material changes from the risk factors previously disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2022[235](index=235&type=chunk) [Exhibits](index=45&type=section&id=Item%206.%20Exhibits) This section provides an index of exhibits filed with the report, including CEO and CFO certifications and XBRL data files - The exhibit index lists required filings, including Sarbanes-Oxley Act certifications (Exhibits 31.1, 31.2, 32.1) and XBRL data (Exhibit 101)[238](index=238&type=chunk)

Great Elm Group, Inc. (NASDAQ:GEG) Q4 2022 Results Conference Call September 12, 2022 9:00 AM ET Company Participants Adam Yates - Managing Director Peter Reed - Chief Executive Officer Adam Kleinman - President Brent Pearson - CFO & CAO Conference Call Participants Brian Alexitch - Greenwich Investment Management Operator Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Great Elm Group Fiscal 2022 Fourth Quarter Results Confer ...